Datroway significantly improves overall and progression-free survival in metastatic triple-negative breast cancer patients ineligible for immunotherapy. TROPION-Breast02 trial results highlight ...
Hosted on MSN
Study uncovers how beta blockers could halt the progression of triple negative breast cancer
Monash University researchers have identified a molecular biomarker in triple negative breast cancer (TNBC) tumors which could inform when beta blockers can play a role in "switching off" tumor ...
Trodelvy reduced risk of disease progression or death versus chemotherapy in patients with previously untreated metastatic triple-negative breast cancer. Treatment with Trodelvy (Sacituzumab govitecan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback